» Articles » PMID: 19388006

On the Assessment of Cerebrovascular Reactivity Using Hypercapnia BOLD MRI

Overview
Journal NMR Biomed
Publisher Wiley
Date 2009 Apr 24
PMID 19388006
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebrovascular reactivity (CVR) reflects the capacity of blood vessels to dilate and is an important marker for brain vascular reserve. It may provide a useful addition to the traditional baseline blood flow measurement when assessing vascular factors in brain disorders. Blood-oxygenation-level-dependent MRI under CO(2) inhalation offers a non-invasive and quantitative means to estimate CVR in humans. In this study, we investigated several important methodological aspects of this technique with the goal of optimizing the experimental and data processing strategies for clinical use. Comparing 4 min of 5% CO(2) inhalation (less comfortable) to a 1 min inhalation (more comfortable) duration, it was found that the CVR values were 0.31 +/- 0.05%/mmHg (N = 11) and 0.31 +/- 0.08%/mmHg (N = 9), respectively, showing no significant differences between the two breathing paradigms. Therefore, the 1 min paradigm is recommended for future application studies for patient comfort and tolerability. Furthermore, we have found that end-tidal CO(2) recording was useful for accurate quantification of CVR because it provided both timing and amplitude information regarding the input function to the brain vascular system, which can be subject-dependent. Finally, we show that inter-subject variations in CVR are of physiologic origin and affect the whole brain in a similar fashion. Based on this, it is proposed that relative CVR (normalized against the CVR of the whole brain or a reference tissue) may be a more sensitive biomarker than absolute CVR in clinical applications as it minimizes inter-subject variations. With these technological optimizations, CVR mapping may become a useful method for studies of neurological and psychiatric diseases.

Citing Articles

Alterations of cerebrovascular reactivity following pediatric mild traumatic brain injury are independent of neurodevelopmental changes.

van der Horn H, Dodd A, Wick T, Robertson-Benta C, McQuaid J, Erhardt E J Cereb Blood Flow Metab. 2024; 45(1):125-139.

PMID: 39113416 PMC: 11572250. DOI: 10.1177/0271678X241270531.


Improved cerebrovascular reactivity mapping using coherence weighted general linear model in the frequency domain.

Xu B, Vu C, Borzage M, Gonzalez-Zacarias C, Shen J, Wood J Neuroimage. 2023; 284:120448.

PMID: 37952392 PMC: 10822713. DOI: 10.1016/j.neuroimage.2023.120448.


Associations of Cerebrovascular Regulation and Arterial Stiffness With Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.

Scheuermann B, Parr S, Schulze K, Kunkel O, Turpin V, Liang J J Am Heart Assoc. 2023; 12(23):e032616.

PMID: 37930079 PMC: 10727345. DOI: 10.1161/JAHA.123.032616.


Detection and Mitigation of Neurovascular Uncoupling in Brain Gliomas.

Agarwal S, Welker K, Black D, Little J, DeLone D, Messina S Cancers (Basel). 2023; 15(18).

PMID: 37760443 PMC: 10527022. DOI: 10.3390/cancers15184473.


Dependence of resting-state-based cerebrovascular reactivity (CVR) mapping on spatial resolution.

Liu P, Hu B, Kartchner L, Joshi P, Xu C, Jiang D Front Neuroimaging. 2023; 2:1205459.

PMID: 37554643 PMC: 10406303. DOI: 10.3389/fnimg.2023.1205459.


References
1.
van den Boom R, Oberstein S, Spilt A, Behloul F, Ferrari M, Haan J . Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab. 2003; 23(5):599-604. DOI: 10.1097/01.WCB.0000062341.61367.D3. View

2.
Cohen E, Rostrup E, Sidaros K, Lund T, Paulson O, Ugurbil K . Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences. Neuroimage. 2004; 23(2):613-24. DOI: 10.1016/j.neuroimage.2004.06.021. View

3.
Hetzel A, Braune S, Guschlbauer B, Dohms K . CO2 reactivity testing without blood pressure monitoring?. Stroke. 1999; 30(2):398-401. DOI: 10.1161/01.str.30.2.398. View

4.
Weiss J, Sumpio B . Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur J Vasc Endovasc Surg. 2005; 31(2):143-50. DOI: 10.1016/j.ejvs.2005.08.015. View

5.
Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, OBanion M . ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008; 11(4):420-2. PMC: 2895310. DOI: 10.1038/nn2073. View